drugset / Trial / NCT00314132
Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis.
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to assess whether ChimeriVax™ JE vaccine (a new vaccine to be used for vaccination against Japanese encephalitis) is safe and well tolerated when compared to placebo (dummy) vaccination.
Timeline
- Start
- 2005-10
- Primary completion
- 2006-11
- Completion
- 2006-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ChimeriVax™-JE | Vaccine | 0.5 ml | Subcutaneous |